NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

Let me provide a solution to this dilemma and situation. Essentially, what you and others say is that we need a top journal publication for validation with the investment community. I do not think anyone in medicine will question the results put forth by roughly 70 of their top experts with any sincerely, and they will not care if it is NEJM or Neurooncology (Lancet and JAMA are not worth the wait).

So the answer is risk the pickiest journal in the world which gives preferential treatment to lead authors or companies based in New England (neither of which applies to us here), or send it to Neurooncology and SNO whose editors and reviewers are one in the same and responsible for both executing a top notch meeting and keeping regular articles about Neurooncology flowing despite the existence of COVID like they and every other journal, investigator and company has managed to do.

I will outline to steps. Analyze the data, chose to include a SAB along with key investigator to review the data, work with lead investigators to draft the introduction (Linda Liau can take an Ambien and write that during the amnestic wakeful episode she has in the middle of the night) and discussion sections, work with your medical writer to clean those up and add Methods and Results sections, submit to the Society of Neurooncology for review as both a LBA and an article for press (the LBA can be submitted before LP and KA complete their discussion piece, but the paper would need this before completing that, allow LL and KA to use part of the weekly academic office hours which is dedicated time set aside for researching academicians to do whatever they need to do outside the lab or clinic to review comments and work with NWBO to write the response, present dats/publish data with the international Society for Neurooncology.

I believe that is six easy steps to follow in order to ensure you get both the top presentation platform for Neurooncology and the most read journal by Neurooncologists. Neurooncology is your top tier journal that provides you the highest degree of certainty coupled with the best exposure to your target audience.

Not rocket science or Brain Surgery, but I can recommend two Brain Surgeons to help out